Human Molecular Genetics, Vol 8, 839-846, Copyright © 1999 by Oxford University Press
MT Usdin, PF Shelbourne, RM Myers and DV Madison
Cognitive impairment is an early symptom of Huntington's disease (HD). Mice
engineered to carry the HD mutation in the endogenous huntingtin gene
showed a significant reduction in long-term potentiation (LTP), a measure
of synaptic plasticity often thought to be involved in memory. However, LTP
could be induced in mutant slices by an 'enhanced' tetanic stimulus,
implying that the LTP-producing mechanism is intact in mutant mice, but
that their synapses are less able to reach the threshold for LTP induction.
Mutant mice showed less post-tetanic potentiation than wild-type animals,
and also showed decreased paired pulse facilitation, suggesting that
excitatory synapses in HD mutant mice are impaired in their ability to
sustain transmission during repetitive stimulation. We show that mutants,
while normal in their ability to transmit at low frequencies, released
significantly less glutamate during higher frequency synaptic activation.
Thus, a reduced ability of Huntington synapses to respond to repetitive
synaptic demand of even moderate frequency could result not only in a
functional impairment of LTP induction, but could also serve as a substrate
for the cognitive symptoms that comprise the early-stage pathology of HD.
ARTICLES
Impaired synaptic plasticity in mice carrying the Huntington's disease mutation
Department of Genetics, B111 Beckman Center, Stanford University School of Medicine, Stanford, CA 94305, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. O. Bauer, H. K. Wong, F. Oyama, A. Goswami, M. Okuno, Y. Kino, H. Miyazaki, and N. Nukina Inhibition of Rho Kinases Enhances the Degradation of Mutant Huntingtin J. Biol. Chem., May 8, 2009; 284(19): 13153 - 13164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Simmons, C. S. Rex, L. Palmer, V. Pandyarajan, V. Fedulov, C. M. Gall, and G. Lynch Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice PNAS, March 24, 2009; 106(12): 4906 - 4911. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Sato, M. Miura, M. Yamada, T. Yoshida, J. D. Wood, I. Yazawa, M. Masuda, T. Suzuki, R.-M. Shin, H.-J. Yau, et al. Severe neurological phenotypes of Q129 DRPLA transgenic mice serendipitously created by en masse expansion of CAG repeats in Q76 DRPLA mice Hum. Mol. Genet., February 15, 2009; 18(4): 723 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, C.-E. Wang, A. Orr, S. Tydlacka, S.-H. Li, and X.-J. Li Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice J. Cell Biol., March 24, 2008; 180(6): 1177 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Milnerwood and L. A. Raymond Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load J. Physiol., December 15, 2007; 585(3): 817 - 831. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Parker, M. Metzler, J. Georgiou, M. Mage, J. C. Roder, A. M. Rose, M. R. Hayden, and C. Neri Huntingtin-Interacting Protein 1 Influences Worm and Mouse Presynaptic Function and Protects Caenorhabditis elegans Neurons against Mutant Polyglutamine Toxicity J. Neurosci., October 10, 2007; 27(41): 11056 - 11064. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuhn, D. R. Goldstein, A. Hodges, A. D. Strand, T. Sengstag, C. Kooperberg, K. Becanovic, M. A. Pouladi, K. Sathasivam, J.-H. J. Cha, et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage Hum. Mol. Genet., August 1, 2007; 16(15): 1845 - 1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Chiang, C.-G. Juo, H.-H. Chang, H.-M. Chen, E. C. Yi, and Y. Chern Systematic Uncovering of Multiple Pathways Underlying the Pathology of Huntington Disease by an Acid-cleavable Isotope-coded Affinity Tag Approach Mol. Cell. Proteomics, May 1, 2007; 6(5): 781 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lynch, E. A. Kramar, C. S. Rex, Y. Jia, D. Chappas, C. M. Gall, and D. A. Simmons Brain-Derived Neurotrophic Factor Restores Synaptic Plasticity in a Knock-In Mouse Model of Huntington's Disease J. Neurosci., April 18, 2007; 27(16): 4424 - 4434. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Latouche, C. Lasbleiz, E. Martin, V. Monnier, T. Debeir, A. Mouatt-Prigent, M.-P. Muriel, L. Morel, M. Ruberg, A. Brice, et al. A Conditional Pan-Neuronal Drosophila Model of Spinocerebellar Ataxia 7 with a Reversible Adult Phenotype Suitable for Identifying Modifier Genes J. Neurosci., March 7, 2007; 27(10): 2483 - 2492. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Cummings, A. J. Milnerwood, G. M. Dallerac, V. Waights, J. Y. Brown, S. C. Vatsavayai, M. C. Hirst, and K. P.S.J. Murphy Aberrant cortical synaptic plasticity and dopaminergic dysfunction in a mouse model of huntington's disease Hum. Mol. Genet., October 1, 2006; 15(19): 2856 - 2868. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Milnerwood, D. M. Cummings, G. M. Dallerac, J. Y. Brown, S. C. Vatsavayai, M. C. Hirst, P. Rezaie, and K. P.S.J. Murphy Early development of aberrant synaptic plasticity in a mouse model of Huntington's disease Hum. Mol. Genet., May 15, 2006; 15(10): 1690 - 1703. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Mazarakis, A. Cybulska-Klosowicz, H. Grote, T. Pang, A. Van Dellen, M. Kossut, C. Blakemore, and A. J. Hannan Deficits in Experience-Dependent Cortical Plasticity and Sensory-Discrimination Learning in Presymptomatic Huntington's Disease Mice J. Neurosci., March 23, 2005; 25(12): 3059 - 3066. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Li and X.-J. Li Huntington and its Role in Neuronal Degeneration Neuroscientist, October 1, 2004; 10(5): 467 - 475. [Abstract] [PDF] |
||||
![]() |
W.-C. M. Lee, M. Yoshihara, and J. T. Littleton Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease PNAS, March 2, 2004; 101(9): 3224 - 3229. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Miller, L. A. Swayne, L. Chen, Z.-P. Feng, J. L. Wacker, P. J. Muchowski, G. W. Zamponi, and J. E. A. Braun Cysteine String Protein (CSP) Inhibition of N-type Calcium Channels Is Blocked by Mutant Huntingtin J. Biol. Chem., December 26, 2003; 278(52): 53072 - 53081. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michalik and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet., October 15, 2003; 12(90002): R173 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, T. Wyman, Z.-X. Yu, S.-H. Li, and X.-J. Li Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release Hum. Mol. Genet., August 15, 2003; 12(16): 2021 - 2030. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Modregger, N. A. DiProspero, V. Charles, D. A. Tagle, and M. Plomann PACSIN 1 interacts with huntingtin and is absent from synaptic varicosities in presymptomatic Huntington's disease brains Hum. Mol. Genet., October 2, 2002; 11(21): 2547 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Menalled, J. D. Sison, Y. Wu, M. Olivieri, X.-J. Li, H. Li, S. Zeitlin, and M.-F. Chesselet Early Motor Dysfunction and Striosomal Distribution of Huntingtin Microaggregates in Huntington's Disease Knock-In Mice J. Neurosci., September 15, 2002; 22(18): 8266 - 8276. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. L. Xu, J. M. Olson, and L. P. Zhao A regression-based method to identify differentially expressed genes in microarray time course studies and its application in an inducible Huntington's disease transgenic model Hum. Mol. Genet., August 15, 2002; 11(17): 1977 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Klapstein, R. S. Fisher, H. Zanjani, C. Cepeda, E. S. Jokel, M.-F. Chesselet, and M. S. Levine Electrophysiological and Morphological Changes in Striatal Spiny Neurons in R6/2 Huntington's Disease Transgenic Mice J Neurophysiol, December 1, 2001; 86(6): 2667 - 2677. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, S.-H. Li, Z.-X. Yu, P. Shelbourne, and X.-J. Li Huntingtin Aggregate-Associated Axonal Degeneration is an Early Pathological Event in Huntington's Disease Mice J. Neurosci., November 1, 2001; 21(21): 8473 - 8481. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wyttenbach, J. Swartz, H. Kita, T. Thykjaer, J. Carmichael, J. Bradley, R. Brown, M. Maxwell, A. Schapira, T. F. Orntoft, et al. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease Hum. Mol. Genet., August 1, 2001; 10(17): 1829 - 1845. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Petersen, K. E. Larsen, G. G. Behr, N. Romero, S. Przedborski, P. Brundin, and D. Sulzer Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration Hum. Mol. Genet., June 1, 2001; 10(12): 1243 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Orr Beyond the Qs in the polyglutamine diseases Genes & Dev., April 15, 2001; 15(8): 925 - 932. [Full Text] |
||||
![]() |
C.-H. Lin, S. Tallaksen-Greene, W.-M. Chien, J. A. Cearley, W. S. Jackson, A. B. Crouse, S. Ren, X.-J. Li, R. L. Albin, and P. J. Detloff Neurological abnormalities in a knock-in mouse model of Huntington's disease Hum. Mol. Genet., January 1, 2001; 10(2): 137 - 144. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kennedy and P. F. Shelbourne Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? Hum. Mol. Genet., October 1, 2000; 9(17): 2539 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. S. J. Murphy, R. J. Carter, L. A. Lione, L. Mangiarini, A. Mahal, G. P. Bates, S. B. Dunnett, and A. J. Morton Abnormal Synaptic Plasticity and Impaired Spatial Cognition in Mice Transgenic for Exon 1 of the Human Huntington's Disease Mutation J. Neurosci., July 1, 2000; 20(13): 5115 - 5123. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Cummings and H. Y. Zoghbi Fourteen and counting: unraveling trinucleotide repeat diseases Hum. Mol. Genet., April 1, 2000; 9(6): 909 - 916. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lorenzetti, K. Watase, B. Xu, M. M. Matzuk, H. T. Orr, and H. Y. Zoghbi Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus Hum. Mol. Genet., March 22, 2000; 9(5): 779 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Lione, R. J. Carter, M. J. Hunt, G. P. Bates, A. J. Morton, and S. B. Dunnett Selective Discrimination Learning Impairments in Mice Expressing the Human Huntington's Disease Mutation J. Neurosci., December 1, 1999; 19(23): 10428 - 10437. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sun, A. Savanenin, P. H. Reddy, and Y. F. Liu Polyglutamine-expanded Huntingtin Promotes Sensitization of N-Methyl-D-aspartate Receptors via Post-synaptic Density 95 J. Biol. Chem., June 29, 2001; 276(27): 24713 - 24718. [Abstract] [Full Text] [PDF] |
||||









